FFCP PHASE1:Mm9::chr17:84128532..84128542,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=17|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:84128532..84128542,+|id=chr17:84128532..84128542,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0004176!9.35e-30!17;UBERON:0009196!9.35e-30!17;UBERON:0009117!9.35e-30!17;UBERON:0000991!4.38e-28!18;UBERON:0005564!4.38e-28!18;UBERON:0000473!8.26e-28!14;UBERON:0003135!6.07e-26!15;UBERON:0003101!2.61e-24!16;UBERON:0000079!2.61e-24!16;UBERON:0003133!5.64e-21!24;UBERON:0005156!2.48e-19!26;UBERON:0000990!2.48e-19!26;UBERON:0002323!1.88e-13!37;UBERON:0004458!1.88e-13!37;UBERON:0003886!4.39e-13!38;UBERON:0002553!9.78e-13!39;UBERON:0000464!1.54e-08!57|ontology_enrichment_uberon_v019_2=UBERON:0000473,6.28e-15,14;UBERON:0003135,5.35e-14,15;UBERON:0003101,3.50e-13,16;UBERON:0000079,3.50e-13,16;UBERON:0004176,1.84e-12,17;UBERON:0009196,1.84e-12,17;UBERON:0009117,1.84e-12,17;UBERON:0000991,8.03e-12,18;UBERON:0005564,8.03e-12,18;UBERON:0003133,4.35e-09,24;UBERON:0005156,1.87e-08,26;UBERON:0000990,1.87e-08,26|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.44573593256819,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.22836775943812,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.35613120733451,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.76431526421028,0,0.165458490457098,0,0,0,0.234714477291508,0.39061315453185,0.314578033277133,8.21386010808421,5.76060012515731,0,0,0,0,0,0.198681354781265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr17:84128532..84128542,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=17 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:84128532..84128542,+ | |||
|description=CAGE_peak_at_chr17:84128532..84128542,+ | |||
|id=chr17:84128532..84128542,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0004176!9.35e-30!17;UBERON:0009196!9.35e-30!17;UBERON:0009117!9.35e-30!17;UBERON:0000991!4.38e-28!18;UBERON:0005564!4.38e-28!18;UBERON:0000473!8.26e-28!14;UBERON:0003135!6.07e-26!15;UBERON:0003101!2.61e-24!16;UBERON:0000079!2.61e-24!16;UBERON:0003133!5.64e-21!24;UBERON:0005156!2.48e-19!26;UBERON:0000990!2.48e-19!26;UBERON:0002323!1.88e-13!37;UBERON:0004458!1.88e-13!37;UBERON:0003886!4.39e-13!38;UBERON:0002553!9.78e-13!39;UBERON:0000464!1.54e-08!57 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000473,6.28e-15,14;UBERON:0003135,5.35e-14,15;UBERON:0003101,3.50e-13,16;UBERON:0000079,3.50e-13,16;UBERON:0004176,1.84e-12,17;UBERON:0009196,1.84e-12,17;UBERON:0009117,1.84e-12,17;UBERON:0000991,8.03e-12,18;UBERON:0005564,8.03e-12,18;UBERON:0003133,4.35e-09,24;UBERON:0005156,1.87e-08,26;UBERON:0000990,1.87e-08,26 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.44573593256819,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.22836775943812,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.35613120733451,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.76431526421028,0,0.165458490457098,0,0,0,0.234714477291508,0.39061315453185,0.314578033277133,8.21386010808421,5.76060012515731,0,0,0,0,0,0.198681354781265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr17:84128532..84128542,+ | |||
}} |
Latest revision as of 09:59, 5 August 2015
Short description: | p@chr17:84128532..84128542, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:84128532..84128542, + |
Coexpression cluster: | MCL_coexpression_mm9:17 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
testis | 6.28e-15 | 14 |
male reproductive organ | 5.35e-14 | 15 |
male organism | 3.50e-13 | 16 |
male reproductive system | 3.50e-13 | 16 |
external genitalia | 1.84e-12 | 17 |
indifferent external genitalia | 1.84e-12 | 17 |
indifferent gonad | 1.84e-12 | 17 |
gonad | 8.03e-12 | 18 |
gonad primordium | 8.03e-12 | 18 |
reproductive organ | 4.35e-09 | 24 |
reproductive structure | 1.87e-08 | 26 |
reproductive system | 1.87e-08 | 26 |